Author: Mike Lauer

A Reflection on Impact

May 26, 2022
By

It’s worth reflecting that it has been more than two years since the COVID-19 pandemic began. Let’s look back to the months of early to mid-2020 when the nation (and the rest of the world) faced a “novel” coronavirus, one which we knew could be fatal and for which there was little knowledge about how it spreads and no known effective treatment, limited diagnostic tests, and no vaccine. How did NIH make fast and meaningful contributions to respond to the pandemic?

, ,

0 Comments

Congress Strengthens NIH’s Ability To Address Harassment in NIH-funded Activities

May 10, 2022
By and

The recently passed Consolidated Appropriations Act for fiscal year 2022 includes “Section 239,” which is a milestone in our efforts to ensure safe working conditions for people engaged in NIH-supported research. The law requires NIH grant recipients to notify us when their senior key personnel are removed from their position or are otherwise disciplined due to concerns about harassment, bullying, retaliation, or hostile working conditions. This is a major step in our continued effort to change the culture of harassment in biomedical science.

,

16 Comments

Reducing Administrative Burden in Laboratory Animal Research: What Have We Done Recently and What’s Coming…

April 20, 2022
By and

The 21st Century Cures Act called for NIH to collaborate with the U.S. Department of Agriculture and Food and Drug Administration to reduce administrative burdens associated with laboratory animal research programs, while maintaining high standards of animal welfare as well as the integrity and credibility of the research. We jointly released a final report in 2019 outlining steps to accomplish this goal, and have since worked together to implement many of the recommendations. We wanted to take this opportunity today to share some of NIH’s progress and how you can remain involved.

, ,

0 Comments